Chromium and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Chromium (chromium), especially for people who are female, 60+ old, also take Vitamin C, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Nosebleed when taking Chromium. It is created by eHealthMe based on reports of 2,244 people who have side effects when taking Chromium from the FDA, and is updated regularly.

What is Chromium?

Chromium has active ingredients of chromium. It is often used in metabolism. eHealthMe is studying from 2,557 Chromium users. Check the latest studies of Chromium.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,081 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 09, 2026

2,244 people reported to have side effects when taking Chromium.
Among them, 28 people (1.25%) have Nosebleed.

Among these 28 people:

What is the gender of people who have Nosebleed when taking Chromium? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Nosebleed when taking Chromium? *

What are other drugs people take besides Chromium? *

What are other side effects people have besides Nosebleed? *

Fatigue (feeling of tiredness): 10 people, 35.71%
Diarrhea: 10 people, 35.71%
Headache (pain in head): 9 people, 32.14%
Oral Pain: 8 people, 28.57%
Constipation: 7 people, 25.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 7 people, 25.00%
Herpes Virus Infection: 7 people, 25.00%
Infusion Site Swelling: 6 people, 21.43%
Food Craving: 6 people, 21.43%
Infusion Site Scar: 6 people, 21.43%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 21.43%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 17.86%
Breast Cancer: 2 people, 7.14%
Renal Cell Carcinoma (a kidney cancer): 2 people, 7.14%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 7.14%
Urinary Tract Infection: 1 person, 3.57%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.57%
Atrophic Vulvovaginitis (inflammation of the vulva): 1 person, 3.57%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Chromium and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Chromium:

Chromium (2,557 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Chromium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,081 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,091 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chromium (the active ingredients of Chromium) and Chromium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.